North Crest Asset Manangement, LLC Abb Vie Inc. Put Options Transaction History

North Crest Asset Manangement, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Oct 23, 2024	BUY	$163.84 - $199.33 $401,244 - $488,159	2,449 Added 4801.96%	2,500 $493,000
Q2 2024 Jul 16, 2024	SELL	$154.79 - $180.76 $115,937 - $135,389	-749 Reduced 93.63%	51 $8,000
Q4 2023 Jan 30, 2024	SELL	$137.6 - $154.97 $233,920 - $263,449	-1,700 Reduced 68.0%	800 $123,000
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $333,975 - $386,625	2,500 New	2,500 $372,000
Q1 2023 Apr 25, 2023	BUY	$144.61 - $166.54 $361,525 - $416,350	2,500 New	2,500 $398,000

4,095

1.28B

16.7M

15M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

Stay updated on North Crest Asset Manangement, LLC with notifications on news.